| Colony-stimulating factors for febrile neutropenia during cancer therapy CL Bennett, B Djulbegovic, LAB Norris, JO Armitage New England Journal of Medicine 368 (12), 1131-1139, 2013 | 222 | 2013 |
| Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project KR Carson, SD Newsome, EJ Kim, ND Wagner‐Johnston, G Von Geldern, ... Cancer 120 (16), 2464-2471, 2014 | 145 | 2014 |
| Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease CL Bennett, ZP Qureshi, AO Sartor, LAB Norris, A Murday, S Xirasagar, ... Clinical kidney journal 5 (1), 82-88, 2012 | 99 | 2012 |
| Intravenous ibuprofen: the first injectable product for the treatment of pain and fever PB Bookstaver, AD Miller, CN Rudisill, LAB Norris Journal of pain research, 67-79, 2010 | 94 | 2010 |
| Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients LAB Norris, F Kablaoui, MK Brilhart, PB Bookstaver International journal of antimicrobial agents 50 (3), 308-317, 2017 | 76 | 2017 |
| Hepatitis B virus reactivation: risk factors and current management strategies DJ Smalls, RE Kiger, LAB Norris, CL Bennett, BL Love Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39 (12 …, 2019 | 69 | 2019 |
| Assessing pharmacy residents' knowledge of biostatistics and research study design PB Bookstaver, AD Miller, TM Felder, DL Tice, LAB Norris, SS Sutton Annals of Pharmacotherapy 46 (7-8), 991-999, 2012 | 64 | 2012 |
| Pharmacists' roles in oncology pharmacy services: Results of a global survey LM Holle, CS Harris, A Chan, RJ Fahrenbruch, BA Labdi, JE Mohs, ... Journal of Oncology Pharmacy Practice 23 (3), 185-194, 2017 | 61 | 2017 |
| A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: a report from the Southern … CL Bennett, DM Spiegel, IC Macdougall, LA Norris, ZP Qureshi, O Sartor, ... Seminars in thrombosis and hemostasis 38 (08), 783-796, 2012 | 51 | 2012 |
| Generic oncology drugs: are they all safe? YT Yang, S Nagai, BK Chen, ZP Qureshi, AA Lebby, S Kessler, ... The lancet oncology 17 (11), e493-e501, 2016 | 50 | 2016 |
| Stability and compatibility of antimicrobial lock solutions PB Bookstaver, KEE Rokas, LAB Norris, JM Edwards, RJ Sherertz American journal of health-system pharmacy 70 (24), 2185-2198, 2013 | 45 | 2013 |
| Multiple toxic effects of low-dose methotrexate in a patient treated for psoriasis PB Bookstaver, LA Norris, C Rudisill, T DeWitt, S Aziz, J Fant American Journal of Health-System Pharmacy 65 (22), 2117-2121, 2008 | 45 | 2008 |
| Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye’s syndrome. a report from the Southern Network on Adverse … CL Bennett, KM Starko, HS Thomsen, S Cowper, O Sartor, IC Macdougall, ... Journal of general internal medicine 27, 1697-1703, 2012 | 41 | 2012 |
| Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network. K Kaur, R Fayad, A Saxena, N Frizzell, A Chanda, S Das, S Chatterjee, ... The Journal of community and supportive oncology 14 (2), 54-65, 2016 | 39 | 2016 |
| Polysorbate 80 hypersensitivity reactions: a renewed call to action LAB Norris, ZP Qureshi, PB Bookstaver, DW Raisch, O Sartor, H Chen, ... Community Oncology 9 (7), 425-428, 2010 | 38 | 2010 |
| Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication DW Raisch, W Campbell, V Garg, ZP Qureshi, PB Bookstaver, LAB Norris, ... Expert opinion on drug safety 10 (4), 521-528, 2011 | 36 | 2011 |
| Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR) RA Sabol, V Noxon, O Sartor, JR Berger, Z Qureshi, DW Raisch, ... Cancer Medicine 6 (7), 1541-1551, 2017 | 29 | 2017 |
| Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States ZP Qureshi, LA Norris, O Sartor, JM McKoy, J Armstrong, DW Raisch, ... Journal of Oncology Practice 8 (2), 84-90, 2012 | 24 | 2012 |
| Regulatory and clinical experiences with biosimilar filgrastim in the US, the European Union, Japan, and Canada B Chen, S Nagai, JO Armitage, B Witherspoon, C Nabhan, AC Godwin, ... The oncologist 24 (4), 537-548, 2019 | 23 | 2019 |
| Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia. CL Bennett, JR Berger, O Sartor, KR Carson, WJ Hrushesky, ... British Journal of Haematology 180 (2), 2018 | 21 | 2018 |
